These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23445497)

  • 1. Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates.
    Yin Q; Tong R; Xu Y; Baek K; Dobrucki LW; Fan TM; Cheng J
    Biomacromolecules; 2013 Mar; 14(3):920-9. PubMed ID: 23445497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates.
    Tong R; Cheng J
    Bioconjug Chem; 2010 Jan; 21(1):111-21. PubMed ID: 20000458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles.
    Tong R; Cheng J
    J Am Chem Soc; 2009 Apr; 131(13):4744-54. PubMed ID: 19281160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells.
    Tong R; Yala L; Fan TM; Cheng J
    Biomaterials; 2010 Apr; 31(11):3043-53. PubMed ID: 20122727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin as a "Trojan Horse" for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting.
    Yin Q; Tang L; Cai K; Yang X; Yin L; Zhang Y; Dobrucki LW; Helferich WG; Fan TM; Cheng J
    Biomater Sci; 2018 May; 6(5):1189-1200. PubMed ID: 29570190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapy.
    Tang L; Tong R; Coyle VJ; Yin Q; Pondenis H; Borst LB; Cheng J; Fan TM
    ACS Nano; 2015 May; 9(5):5072-81. PubMed ID: 25938427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of l-Amino-Acid-Based Hydroxyl Functionalized Biodegradable Amphiphilic Polyesters and Their Drug Delivery Capabilities to Cancer Cells.
    Saxena S; Jayakannan M
    Biomacromolecules; 2020 Jan; 21(1):171-187. PubMed ID: 31592651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-polyester conjugated nanoparticles for cancer drug delivery.
    Tong R; Tang L; Yin Q; Cheng J
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():8337-9. PubMed ID: 22256280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(amino acid)-polyester graft copolymer nanoparticles for the acid-mediated release of doxorubicin.
    Price DJ; Khuphe M; Davies RPW; McLaughlan JR; Ingram N; Thornton PD
    Chem Commun (Camb); 2017 Aug; 53(62):8687-8690. PubMed ID: 28722060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic block co-polyesters bearing pendant cyclic ketal groups as nanocarriers for controlled release of camptothecin.
    Wang X; Gurski LA; Zhong S; Xu X; Pochan DJ; Farach-Carson MC; Jia X
    J Biomater Sci Polym Ed; 2011; 22(10):1275-98. PubMed ID: 20594408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates.
    Tang L; Gabrielson NP; Uckun FM; Fan TM; Cheng J
    Mol Pharm; 2013 Mar; 10(3):883-92. PubMed ID: 23301497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
    Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
    Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphilic Y shaped miktoarm star copolymer for anticancer hydrophobic and hydrophilic drugs codelivery: Synthesis, characterization, in vitro, and in vivo biocompatibility study.
    Aghajanzadeh M; Zamani M; Rashidzadeh H; Rostamizadeh K; Sharafi A; Danafar H
    J Biomed Mater Res A; 2018 Nov; 106(11):2817-2826. PubMed ID: 29908009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro cytotoxicity and combination effects of the docetaxel-conjugated and doxorubicin-conjugated poly(lactic acid)-poly(ethylene glycol)-folate-based polymeric micelles in human ovarian cancer cells.
    Hami Z; Rezayat SM; Gilani K; Amini M; Ghazi-Khansari M
    J Pharm Pharmacol; 2017 Feb; 69(2):151-160. PubMed ID: 28044342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a docetaxel micellar formulation using poly(ethylene glycol)-polylactide-poly(ethylene glycol) (PEG-PLA-PEG) with successful reconstitution for tumor targeted drug delivery.
    Sim T; Kim JE; Hoang NH; Kang JK; Lim C; Kim DS; Lee ES; Youn YS; Choi HG; Han HK; Weon KY; Oh KT
    Drug Deliv; 2018 Nov; 25(1):1362-1371. PubMed ID: 29869563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
    Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
    Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
    Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R
    Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.